4.7 (643) In stock
Background Gaining further insights into SARS-CoV-2 routes of infection and the underlying pathobiology of COVID-19 will support the design of rational treatments targeting the life cycle of the virus and/or the adverse effects (e.g., multi-organ collapse) that are triggered by COVID-19-mediated adult respiratory distress syndrome (ARDS) and/or other pathologies. Main body COVID-19 is a two-phase disease being marked by (phase 1) increased virus transmission and infection rates due to the wide expression of the main infection-related ACE2, TMPRSS2 and CTSB/L human genes in tissues of the respiratory and gastrointestinal tract, as well as by (phase 2) host- and probably sex- and/or age-specific uncontrolled inflammatory immune responses which drive hyper-cytokinemia, aggressive inflammation and (due to broad organotropism of SARS-CoV-2) collateral tissue damage and systemic failure likely because of imbalanced ACE/ANGII/AT1R and ACE2/ANG(1–7)/MASR axes signaling. Conclusion Here we discuss SARS-CoV-2 life cycle and a number of approaches aiming to suppress viral infection rates or propagation; increase virus antigen presentation in order to activate a robust and durable adaptive immune response from the host, and/or mitigate the ARDS-related “cytokine storm” and collateral tissue damage that triggers the severe life-threatening complications of COVID-19.
COVID-19: Pathophysiology, treatment options, nanotechnology
Aviptadil - Wikipedia
Immune system response during viral Infections: Immunomodulators
Uprošćena patofiziologija SARS-CoV-2 virusa - Miloš Babić
Insights to SARS-CoV-2 life cycle, pathophysiology, and
PDF) The Natural History of SARS-CoV-2-Incurred Disease: From
The pandemic virus is slowly mutating. But does it matter?
The need for a multi-level drug targeting strategy to curb the
Virology of SARS-COV-2
Biomolecules, Free Full-Text
SARS-CoV-2/COVID-19 and advances in developing potential
Viruses Topical Collection : SARS-CoV-2 and COVID-19
The Natural History, Pathobiology, and Clinical Manifestations of
Frontiers Glutathione deficiency in the pathogenesis of SARS-CoV
